STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$827,609
+4.5%
8,117
-6.8%
0.00%0.0%
Q1 2023$791,640
+133.4%
8,707
-2.5%
0.00%
+100.0%
Q4 2022$339,137
-2.0%
8,927
-35.3%
0.00%0.0%
Q3 2022$346,000
-17.4%
13,7870.0%0.00%0.0%
Q2 2022$419,000
-1.4%
13,787
+6.2%
0.00%0.0%
Q1 2022$425,000
+24.3%
12,9870.0%0.00%0.0%
Q4 2021$342,000
-74.9%
12,987
-4.1%
0.00%
-66.7%
Q3 2021$1,363,000
-25.8%
13,546
+4.4%
0.00%0.0%
Q2 2021$1,836,000
-43.2%
12,976
-60.0%
0.00%
-50.0%
Q1 2021$3,235,000
-19.3%
32,452
+0.1%
0.01%
-25.0%
Q4 2020$4,009,000
+37.2%
32,432
+8.2%
0.01%
+14.3%
Q3 2020$2,921,000
-29.4%
29,983
+13.0%
0.01%
-30.0%
Q2 2020$4,138,000
+187.0%
26,523
+165.4%
0.01%
+150.0%
Q1 2020$1,442,000
-23.3%
9,992
+8.6%
0.00%
-20.0%
Q4 2019$1,881,000
+173.8%
9,202
+7.5%
0.01%
+150.0%
Q3 2019$687,000
-15.0%
8,5620.0%0.00%0.0%
Q2 2019$808,000
+19.7%
8,562
+8.4%
0.00%0.0%
Q1 2019$675,000
+58.1%
7,902
+3.8%
0.00%
+100.0%
Q4 2018$427,000
-24.6%
7,612
+9.9%
0.00%0.0%
Q3 2018$566,000
+133.9%
6,9260.0%0.00%0.0%
Q2 2018$242,0006,9260.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders